Kalkine Media ASX Share Market News & Research
Watchlist Sign Up/Login
Kalkine Media ASX Share Market News & Research

RUA Life Sciences Plc revenue improves to £489,000 for FY20

1 min read | July 13, 2020 02:22 PM BST | By Team Kalkine Media
Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp

Recent News

thumbnail

The Communication Names Growing Far From Home

thumbnail

Why Britain's Cupboard Staples Quietly Run the FTSE 100

thumbnail

Why Britain's Grocery Giant Is a Market Mood Ring

thumbnail

Why a Glass of Something Nice Is a Market Signal

Make Kalkine Media
My Trusted Source

Google Source

RUA Life Sciences Plc (LON:RUA) has released its final results for the year ended 31 March 2020.

  • The company has stated that its revolution continues led by latest strategic acquisition of RUA Medical Devices Limited.
  • Company’s revenue improved to £489,000 as compared to £463,000 for the Year ended 31 March 2019.
  • Company’s Operating loss, however, increased to £941,000 as compared to £632,000 in the previous year.
  • The company is expecting to achieve design finalisation on Vascular products in the coming two months and Structural Heart projects by the year.
  • On 13th July 2020, at the time of writing, GMT 16:29 PM, RUA shares were trading at GBX 102.00, down by 8.00 points or 7.27% against the previous day closing price.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (Kalkine Media, we or us) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalised advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

UK_Premium_Article

Sponsored Articles

1

Top 10 FTSE Listed Dividend Paying Stocks

2

KryptoByte and Archax Partner on Custody Framework for Energy-Derived...

3

Union Jack Oil (AIM:UJO) Unlocks Value with New Discoveries and Operat...

4

Union Jack Oil (LON:UJO) reports strong financials for 1H with £2MM ma...

5

A view of how UK’s lottery industry is embracing internet

Investing Ideas

Previous Next